Axons are essential for neuronal communication but they do not regenerate after injury to the adult mammalian brain or spinal cord. Failed regeneration is due in part to the production of a potent axonal growth inhibitor, Nogo, by myelinating cells. The finding of a high affinity axonal receptor for the extracellular domain of Nogo provides the first insight into the basis of Nogo action. Disrupting the interaction of Nogo with the Nogo-66 receptor may facilitate axonal regeneration in vivo. The protein is dubbed the Nogo receptor because it binds with several other proteins that block neural growth. It is found to be ubiquitous in the brain and spinal cord.
特異性
Cat. # AB15138 recognizes the mature form of Nogo Receptor.
May react with human and primate based on sequence homology. Reactivity with other species has not been determined.
免疫原
Epitope: Mature Form
Recombinant protein.
アプリケーション
Research Category ニューロサイエンス
Research Sub Category 成長円錐及び軸策ガイダンス
Anti-Nogo Receptor Antibody detects level of Nogo Receptor & has been published & validated for use in WB, IH.
Non-Lot Specific Tested Application 1: Immunohistochemistry: Working dilutions of 1:50-1:500 in rat brain and spinal cord (paraffin embedded)
品質
Routinely tested on mouse cerebellum lysate. Lot Specific Tested Application 1: Western Blot
ターゲットの説明
~50.9 kDa
物理的形状
Protein A purified
Format: Purified
Purified in PBS with 0.1% NaN3
保管および安定性
Maintain at 2-8°C in undiluted aliquots for up to 1 year after date of receipt.
アナリシスノート
Control Mouse cerebellum lysate
その他情報
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Experimental and therapeutic medicine, 22(6), 1413-1413 (2021-10-23)
Methylprednisolone (MP) is widely used to treat clinical spinal cord injury (SCI). Treadmill training is also considered an important treatment after SCI to improve motor function in patients, resulting in an evident improvement. Therefore, the present study was designed to
Journal of cell science, 129(6), 1198-1209 (2016-01-31)
Inhibitory proteins, particularly Nogo 66, a highly conserved 66-amino-acid loop of Nogo A (an isoform of RTN4), play key roles in limiting the intrinsic capacity of the central nervous system (CNS) to regenerate after injury. Ligation of surface Nogo receptors
International journal of molecular sciences, 22(19) (2021-10-14)
Dopaminergic treatment in combination with rehabilitative training enhances long-term recovery after stroke. However, the underlying mechanisms on structural plasticity are unknown. Here, we show an increased dopaminergic innervation of the ischemic territory during the first week after stroke induced in